|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0006826,
umls-concept:C0013216,
umls-concept:C0024299,
umls-concept:C0029246,
umls-concept:C0035168,
umls-concept:C0087111,
umls-concept:C0239307,
umls-concept:C0280803,
umls-concept:C0282460,
umls-concept:C0332283,
umls-concept:C1257890,
umls-concept:C1522449
|
|
pubmed:issue |
24
|
|
pubmed:dateCreated |
2003-12-15
|
|
pubmed:abstractText |
To confirm the feasibility and estimate the efficacy of methotrexate (MTX), teniposide, carmustine, and methylprednisolone (MBVP) chemotherapy combined with radiotherapy (RT) for patients with non-AIDS-related primary CNS lymphoma (PCNSL) treated in a multicenter setting.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Dec
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:European Organization for Research and Treatment of Cancer Lymphoma Group,
pubmed-author:FickersMartinM,
pubmed-author:Haaxma-ReicheHannyH,
pubmed-author:HansenMadsM,
pubmed-author:Kluin-NelemansHanneke CHC,
pubmed-author:PoortmansPhilip M PPM,
pubmed-author:RozewiczCynthiaC,
pubmed-author:SoubeyranPierreP,
pubmed-author:TaphoornMartinM,
pubmed-author:TeodorovicIvanaI,
pubmed-author:ThomasJoséJ,
pubmed-author:Van't VeerMarsM,
pubmed-author:Van ImhoffGustaafG,
pubmed-author:Van den BentMartinM,
pubmed-author:van GlabbekeMartineM
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4483-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:14597741-Adolescent,
pubmed-meshheading:14597741-Adult,
pubmed-meshheading:14597741-Aged,
pubmed-meshheading:14597741-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14597741-Carmustine,
pubmed-meshheading:14597741-Central Nervous System Neoplasms,
pubmed-meshheading:14597741-Combined Modality Therapy,
pubmed-meshheading:14597741-Female,
pubmed-meshheading:14597741-Humans,
pubmed-meshheading:14597741-Lymphoma,
pubmed-meshheading:14597741-Male,
pubmed-meshheading:14597741-Methotrexate,
pubmed-meshheading:14597741-Methylprednisolone,
pubmed-meshheading:14597741-Middle Aged,
pubmed-meshheading:14597741-Prospective Studies,
pubmed-meshheading:14597741-Survival Analysis,
pubmed-meshheading:14597741-Teniposide,
pubmed-meshheading:14597741-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
High-dose methotrexate-based chemotherapy followed by consolidating radiotherapy in non-AIDS-related primary central nervous system lymphoma: European Organization for Research and Treatment of Cancer Lymphoma Group Phase II Trial 20962.
|
|
pubmed:affiliation |
Dr Bernard Verbeeten Instituut, PO Box 90120, 5000 LA Tilburg, The Netherlands. poortmans.ph@bvi.nl
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase II
|
